OpenAI outlines new for-profit structure in bid to stay ahead in costly AI race

By Aditya Soni, Arsheeya Bajwa, Krystal Hu (Reuters) -OpenAI on Friday outlined plans to revamp its structure, saying it would create a public benefit corporation to make it easier to “raise more capital than we’d imagined,” and remove the restrictions imposed on the startup by its current nonprofit parent.  The acknowledgement and detailed rationale behind…

Read More

Duke Energy files to recover $1.1 billion in hurricane costs

(Reuters) – U.S.-based utility Duke Energy said on Friday it had filed a plan with the Florida Public Service Commission to recover about $1.1 billion in direct costs associated with the company’s emergency activation and response to hurricanes Debby, Helene and Milton. Duke, the largest utility covering North and South Carolina, said the hurricanes hit…

Read More

Trump nominates Miami-Dade official as ambassador to Panama

By Jasper Ward (Reuters) – U.S. President-elect Donald Trump on Wednesday nominated Miami-Dade County Commissioner Kevin Marino Cabrera to serve as ambassador to Panama. Trump described Cabrera as “a fierce fighter for America First principles” who he said has been instrumental in driving economic growth and fostering international partnerships. “Few understand Latin American politics as…

Read More

US FDA proposes standardized testing to detect asbestos in talc products

(Reuters) – The U.S. Food and Drug Administration is proposing that cosmetic products containing talc should be tested using standardized methods to detect asbestos, a potential contaminant, according to documents posted on the federal register on Thursday. WHY IT’S IMPORTANT Asbestos, a known human carcinogen, can be injurious to consumers if found in talc-containing cosmetic…

Read More

Retail investors buy Novo dip after disappointing weight-loss drug data

By Bhanvi Satija (Reuters) – U.S. retail investor fund flows into Novo Nordisk surged 32-fold on Friday, as the Danish drugmaker’s weaker-than-expected obesity drug data offered a rare dip-buying opportunity, according to Vanda Research. Daily net flows climbed to $15.6 million from $0.49 million a day earlier, after eagerly anticipated data showed Novo’s experimental drug,…

Read More